The market is up, but it’s all theatre: Don’t let The Fed’s buying suck you in

Chris Parry
March 24, 2020
Trust me, there’s nothing I’d like more, as the publisher of a financial markets-focused media outlet, than to tell you all it’s time to buy back in on these ailing markets. I’ve got clients who’d reward me well if I were to convince you that it’d be a good idea to buy their stock in the middle of a stock slide. I’ve got employees that I’m still paying and not laying off that are ready to do their thing and share good investing opportunities with you all, especially at a time when you’re all at home looking for information.

GTEC Holdings (GTEC.C) CEO locks down the future, thumps chest on Twitter

Chris Parry
March 17, 2020
GTEC Holdings (GTEC.C) is a company we've written about a lot, a BC-based cannabis grower that laid out a business model of multiple small licensed grow facilities, hitting the premium artisan weed market. Their products are great, their costs are low, and they've never yet benefited from the irrational weed booms of the '15, '16, and '17 years because they were late to get those licenses. This means, they've experienced all the weed industry dives, but none of the runs. Their stock price: $0.09, good for a market cap of just $11 million.

Flupocalypse 2020: Assuming you stay healthy, this is your ‘get rich’ moment

Chris Parry
March 13, 2020
When the savings and loan crisis in the US hit in 1989, a lot of slow-moving investors lost their dough thinking the worst couldn’t possible happen. When the dotcom bubble burst in 2001, a lot of folks got torn up as stocks that had previously been 100-baggers went to zero. When the real estate market burned to the ground amid the financial crisis of 2008, a lot of folks got pulled under, imagining the worst that could happen couldn’t really happen. When the Canadian weed market started imploding in early 2019, true believers told themselves for months, “It’s bound to come back soon,” even as companies lost 95% of their value

Green Organic Dutchman (TGOD.T) drops fat quarterly loss, underwhelming revenues

Chris Parry
March 10, 2020
No company in the Canadian cannabis space polarizes people like Green Organic Dutchman (TGOD.T), which roared to the public markets on perhaps the biggest promote yet seen, raised nine-digit totals along the way, swept in more first time private placement participants than any company before them, and then did... well... nothing, for a long time. With top brass having been walked recently and plans to super-size the company grow facilities shelved in the wake of underwhelming need for more weed, TGOD has made no secret it is at a moment of recalibration, but investors will have expected to see more than this.

AMPD, PAT, MTA, HIVE, MILE: Contrarian investing as the zombies climb over the walls

Chris Parry
March 9, 2020
Okay, so the world is burning, the Russians and Saudis are pouring low-cost fuel over it, the Americans are shocked that a reality TV show host with a penchant for scams didn’t make a clever President, Italy is in total lockdown, the Japanese are thinking of holding a spectator-free Olympics, Israel is putting anyone coming home from overseas in two weeks of quarantine, the stock markets are taking their biggest dive ever, and morons are hoarding toilet paper and hand sanitizer while lining up for the free havarti samples at Costco.

Shroom stocks go nuts: First movers SHRM, MMED, RVV up hard as gamblers gamble

Chris Parry
March 4, 2020
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who'd listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O'Leary were on board. Champignon Brands (SHRM.C) zoomed 40% to $0.33 on a lot smaller market awareness spend byt a handy ticker, Roadman Investments (LITT.V) was up 30% to $0.065 being sucked along in the other two companies' wake, and Revive Therapeutics (RVV.C) was up 81% to $0.10 on ripples caused by the rest.

Heritage Cannabis (CANN.C) loses $2.3 million in Q4, finds extra year of runway as revenues kick in

Chris Parry
February 28, 2020
A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That's because the company led their Q4 financials news release today with their yearly metrics filling the headlines, while their not-so-rough quarterly numbers were largely and inexplicably hidden from view.

CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine

Chris Parry
February 27, 2020
As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold as a safe haven when the world's leaders engage in a game of 'Armageddon chicken.' a pandemic brings about macroeconomic changes that can be utilised to make money.

Invictus MD Strategies (GENE.V) kicked off Venture Exchange after screwing up everything for three years straight

Chris Parry
February 24, 2020
Invictus MD Strategies (GENE.V) announced tonight that, in accordance with its efforts to work through creditor protection proceedings, it has been kicked off the Venture Exchange. On the upside, if Invictus' history of going back on news releases is anything to go by, we'll receive another release inside ten days that the bankruptcy proceedings have been cancelled and they'll continue on as usual. Because that's how it's always been for Invictus, which has the worst track record in Canada's cannabis space for announcing things, only to un-announce them very shortly after.

2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed

Chris Parry
February 21, 2020
Respect where it's due, I haven't been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year's Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn't the biggest show around, but they know how to turn out the playahs, and the only way you keep big money showing up is to be a little bit picky with what you offer them. Don't waste anyone's time and they'll know it's cool to return.